Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Dr. Andrey Zarur Joins Kodiak Venture Partners

Abstract:
- Life sciences and high technology expert will focus on investing at the intersection of healthcare and IT -

Dr. Andrey Zarur Joins Kodiak Venture Partners

WALTHAM, MA | Posted on February 26th, 2007

Dr. Andrey Zarur has joined Kodiak Venture Partners, a seed and early stage venture capital firm, as General Partner. Zarur will source deals and support Kodiak portfolio companies within the intersection of the healthcare and high technology markets.

Recent years have seen a significant market emerge as a result of the convergence of life sciences and information technology disciplines. Kodiak recognizes this fast-growing market as the evolution of traditional investment areas such as IT and IT-related software and services as they begin to propagate into the healthcare and medical devices markets. The concentration of world class academic centers and teaching hospitals, coupled with a fertile ground for new ventures in these segments, make the Greater Boston area especially attractive for investing in companies focusing on convergence of healthcare and IT. Kodiak has made two investments in this area, ALIS (acquired by Carl Zeiss SMT in July 2006) and Cambridge Devices.

"I am thrilled to join Kodiak and spearhead entry into this exciting market," said Zarur. "The firm's dedication to early stage investing, strong entrepreneurial focus and dynamic team position us for success."

Andrey Zarur, Ph.D., has over 15 years of operating and investing experience. He joins Kodiak from BioProcessors, where he was founder and CEO. Prior to BioProcessors, Zarur served as an executive, investor or board member of over ten startups in areas including bioinformatics, genomics, medical devices, nanotechnology-derived materials and energy systems. He currently serves on the scientific advisory boards of Anecova and StemLife, and serves on the boards of directors of BioProcessors and Cambridge Devices (a Kodiak portfolio company). Zarur is also a director of Infantia, a foundation that provides education and board to underprivileged children in developing countries.

Zarur has earned several prestigious academic and management awards, authored over 20 articles in peer-reviewed journals, counts over 100 issued and pending patents to his name, and lectures at the Sloan School of Management at the Massachusetts Institute of Technology (MIT). He earned a B.Sc. in chemical engineering from the National University of Mexico, and a M.Sc.B. and a Ph.D. in chemical engineering from MIT.

"We have seen the evolution of the IT market over the past few funds, and decided to evolve with it by adding these converging disciplines into our investing focus," said Lou Volpe, Managing General Partner, Kodiak Venture Partners. "We have known and interacted with Andrey for several years and view him as the perfect complement to the Kodiak team—he brings the operational and technological expertise, and hands-on approach of all our partners into investments in these areas."

####

About Kodiak Venture Partners
Kodiak Venture Partners is a Waltham, Mass.-based venture capital firm focused on seed and early stage investments in emerging communications/wireless, semiconductor/equipment, software/services and Internet/new media companies. With a focus in the eastern regions of the U.S. and Canada, Kodiak establishes relationships with entrepreneurs seeking market success. Kodiak’s investment partners are successful high-technology business entrepreneurs who take a hands-on approach to building market leaders.

For more information, please click here

Contacts:
Boldbrook Marketing
Vicki Sakakeeny, 011 506 342 3877

or
Kodiak Venture Partners
Liz Neal, 781-684-0222

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock January 17th, 2018

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Announcements

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock January 17th, 2018

Appointments/Promotions/New hires/Resignations/Deaths

Ocean Optics Grows Sales Organization with Executive Appointments: Henry Langston promoted, Christine Stannard joins spectral sensing product developer December 23rd, 2017

Emmanuel Sabonnadiere is Leti’s New CEO November 28th, 2017

Nanometrics Board of Directors Names Pierre-Yves Lesaicherre President and CEO November 14th, 2017

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project